Choose language / Korean

Join Telegram

Boehringer-Zealand drug leads to 16.6% weight loss in late-stage trial - Reuters
Bull/Bear Index 46.8/100
global_markets BULL 65/10 Reuters via Google News EN · 8h ago

Boehringer-Zealand drug leads to 16.6% weight loss in late-stage trial - Reuters

Boehringer-Zealand's drug showed 16.6% weight loss in a late-stage trial, boosting the pharmaceutical sector.

Get high-impact news instantly

Top stories with score 8/10+ delivered to your Telegram in real time. Free.

Join Telegram channel

📡 Tomorrow's Watch

Related news


BEAR 70/10

SoftBank Group shares tumbled after a report that OpenAI missed several internal targets in the face of competition from rival artificial-intelligence labs.

#global_markets

75/10

It’s good policy and would restore confidence in America’s most important program.

#global_markets

BULL 60/10

Expect the push higher for tech stocks to keep going, says Barclays as Wall Street gets on board. They flag their favorite picks across tech sectors.

#global_markets

BEAR 70/10

Nasdaq opens lower as fresh concerns around AI pressure tech stocks.

#global_markets

10/10

Plus: How to spot ‘ghost jobs’ that could be sabotaging your employment search.

#global_markets

BULL 65/10

Coca-Cola plays down impact of high oil prices to raise profit forecast.

#global_markets